Genome sequencing involves determining the complete set of DNA sequences for your genome. After a detailed analysis and comparison with similar genomes, your DNA can be interpreted according to physical attributes like position, length, and recombination events. DNA sequencing will reveal the human genome and its genetic code. This revolutionary technology promises to revolutionize modern medicine by giving us new insights into our own biology.
Highlighted with 82 tables and 85 figures, this 165-page report “Global Genome Sequencing Market 2020-2030 by Product (Consumables, Sequencers & Software, Service), Technology (PCR, Sequencing, Microarray), Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global genome sequencing market and all its sub-segments through extensively detailed classifications.
Global genome sequencing market will reach $24.37 billion by 2030, growing by 12.6% annually over 2020-2030, driven by the growing government funding to encourage genomics projects, the increasing of the incidence of the cancer and the increasing applications of next-generation sequencing, and the utilization of genomics in specialized or personalized medicine.
Request Research Sample with Latest Industry Insights (170+ Pages Report): https://altusmarketresearch.com/reports/sample/29712
The Genome Sequencing market is a large market, with hundreds of thousands of users worldwide. The primary growth drivers in the genomics industry include increased investment and partnerships between academic institutions, governments and technology companies; new research capabilities; as well as continued demand for industry solutions in the data management market.
The Global Genome Sequencing (GS) market is driven by the relentless rise in technological advancements. The rapid advancement in this technology has created a large number of opportunities for industries by providing better solutions to the verticals.
The genomics market provides a wide range of services and tools that allow researchers to analyze the DNA, RNA and protein sequences of any type of organism.
The challenge of using genomic technologies for product development is the high cost of sequencing. Determining these costs and comparing them with those of other technologies such as microarrays, proteomics, immunoassays and diagnostic tests is an important step in technical and commercial decisions regarding their use.
Based on Product, the global Genome Sequencing Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Consumables
• Sequencers & Software
• Service
Based on Technology, the global Genome Sequencing Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Polymerase Chain Reaction (PCR)
• Sequencing
• Microarray
• Nucleic Acid Extraction and Purification
• Other Technologies
Based on Application, the global Genome Sequencing Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Diagnostics
o Oncology
o Reproductive Health
o Complex Disease Research
o Other Diagnostics
• Drug Discovery and Development
• Precision Medicine
• Agriculture and Animal Research
• Other Applications
By End User, the global Genome Sequencing Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Academic & Research Centers
• Pharmaceutical and Biotechnology Companies
• Consumer Genomic Service Providers
• Government Institutes
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Genome Sequencing Market: Key Players (this may not be a complete list and extra companies can be added upon request):
BGI
Biomatters
Bio-Rad Laboratories, Inc.
DNASTAR
F. Hoffmann-La Roche
Illumina, Inc.
Macrogen Inc.
Myriad Genetics, Inc.
New England Biolabs
Oxford Nanopore Technology
PerkinElmer Inc.
Qiagen
Siemens Healthineers
Thermo Fisher Scientific
